NDC 70710-2007-03 - Deflazacort Oral Suspension
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-2007
- Requested NDC
- 70710-2007-03
- Package NDCs from labels
- 70710-2007-3, 70710-2007-03
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc. | Zydus Lifesciences Global FZE | Doppel Farmaceutici S.r.l.
- Effective date
- 2026-11-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Deflazacort Oral Suspension | Zydus Pharmaceuticals (USA) Inc. | Zydus Lifesciences Global FZE | Doppel Farmaceutici S.r.l. | 2026-11-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-2007-3 | Deflazacort Oral Suspension | 13 mL in 1 BOTTLE | SUSPENSION | 13 | 2 | |
| 70710-2007-3 | Deflazacort Oral Suspension | 1 in 1 CARTON | SUSPENSION | 1 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70710-2007-3 | ML - Milliliter | 70710-2007 | 40ccc302-cbc6-450e-8d85-a62dcaa86388 | 1 | 2026-01-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Refresh Digital | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | b2bd34d4-fab9-4f4b-9be2-5d30b55f5b81 | 2022-11-28 | Warnings | 6OZP39ZG8H K679OBS311 |
| REFRESH OPTIVE | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 7f8d88af-fd3b-4138-af61-f24c59ccebd7 | 2022-09-23 | Warnings | K679OBS311 |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-19 | Warnings | 6OZP39ZG8H K679OBS311 |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | 6OZP39ZG8H K679OBS311 |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | 6OZP39ZG8H K679OBS311 |
| REFRESH PLUS | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | 0f6a4b4b-cde6-4518-84b5-ce997f1154a7 | 2022-06-28 | Warnings | K679OBS311 |
| REFRESH TEARS | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | 329d1fe0-4432-4565-b7b1-65666bd86526 | 2022-06-16 | Warnings | K679OBS311 |
| OHM Fatigue Relief | ACETICUM AC, ADRENAL GLAND, ARNICA, BENZOICUM AC, FERRUM PHOS, FLUORICUM AC, GINSENG, KALI CARB, KALI LOD, KALI MUR, KALI PHOS, LACTICUM AC, PHOSPHORICUM AC, PICRICUM AC. | OHM PHARMA INC. | 419c6315-37de-46b4-8bef-abbeace265b6 | 2021-12-29 | Warnings | Q40Q9N063P |
| Weight Control | ACETICUM AC, ANACARD OR, BARYTA IOD, CALC CARB, CAPSICUM, FUCUS, GRAPHITES,, NAT SULPHURICUM, PHYTOLACCA, STANNUM MET, THYROIDINUM, ZINC MET. | OHM PHARMA INC. | 32b7b539-ee54-4c80-a6d9-c159600927f5 | 2021-12-29 | Warnings | Q40Q9N063P |
| Healthy Start Weight and Appetite Support | ACETICUM ACIDUM, ANACARDIUM ORIENTALE, BARYTA IODATA, CALCAREA CARBONICA, CAPSICUM ANNUM, FUCUS VESICULOSUS, GRAPHITES, NATRUM SULPHURICUM, PHYTOLACCA DECANDRA, STANNUM METALLICUM, THYRDOIDINUM, ZINUM METALLICUM | WELL BODY CONCEPTS LLC | d11b070a-2b55-4b79-933b-c628a38f584e | 2021-12-29 | Warnings | Q40Q9N063P |
| Metabolic Reset | ACETICUM ACIDUM, ANACARDIUM ORIENTALE, BARYTA IODATA, CALCAREA CARBONICA, CAPSICUM ANNUM, FOCUS VERSICULOSUS, GRAPHITES, NATRUM SULPHURICUM, PHYTOLACCA DECANDRA, STANNUM METALLICUM, THYROIDINUM, ZINCUM METALLICUM | Hanoun, Andrew Functional Medicine Inc. | 2a3dd066-ec16-493d-a3b2-2bb5eb2e321c | 2021-01-21 | Warnings | Q40Q9N063P |
| Acetic Acid | ACETIC ACID | Baxter Healthcare Corporation | 41bc12af-fac5-4ac1-b907-dcb3e35a054c | 2018-02-02 | Warnings, Adverse reactions | Q40Q9N063P |
| Ivy-Dry Super | BENZYL ALCOHOL, CAMPHOR, MENTHOL | Ivy-Dry, Inc. | 4792a667-2378-4b3d-968d-9efb1866792f | 2017-12-27 | Warnings | LKG8494WBH |
| Homeoplex D | GLYCERINUM, PHYTOLACCA DECANDRA, TARAXACUM OFFICINALE, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (SUIS), LITHIUM CARBONICUM, THYROIDINUM (SUIS), SALICYLICUM ACIDUM, ADRENOCORTICOTROPHIN, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, | Supplement Clinic, LLC. | cd6b48ab-3566-484d-8deb-15ef6f8e7e8f | 2017-11-01 | Warnings | Q40Q9N063P LKG8494WBH |
| Glucose Control T015 | SYZYGIUM JAMBOLANUM, GLANDULA SUPRARENALIS SUIS, HYDRASTIS CANADENSIS, HYPOPHYSIS SUIS, PANCREAS SUIS, PHASEOLUS, ACETICUM ACIDUM, LACTICUM ACIDUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, URANIUM NITRICUM | Guangzhou Renuma Medical Systems Co., Ltd | 3fd02c0a-5cf1-4f35-86d0-d5d09e63f39b | 2017-10-26 | Warnings | Q40Q9N063P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.